| Dr Kurtis Allen Waters, MD | |
|
13359 Isle Dr, Suite 1, Baxter, MN 56425-2221 | |
| (218) 454-8888 | |
| Not Available |
| Full Name | Dr Kurtis Allen Waters |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 34 Years |
| Location | 13359 Isle Dr, Baxter, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568440717 | NPI | - | NPPES |
| P00409713 | Other | MN | PALMETTO - RAILROAD MEDICARE |
| 422K8WA | Other | MN | BLUE CROSS BLUE SHIELD MN |
| 930218200 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 37843 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cuyuna Regional Medical Center | Crosby, MN | Hospital |
| Riverwood Healthcare Center | Aitkin, MN | Hospital |
| Tri County Hospital | Wadena, MN | Hospital |
| Essentia Health St Joseph's Medical Center | Brainerd, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Specialty Associates | 0446353643 | 4 |
| Astera Health | 2961395272 | 94 |
News Archive
New treatment options are badly needed for acute myeloid leukemia, a relatively rare form of cancer. The malignancy begins in the bone marrow, and from there can spread rapidly to the bloodstream, depriving the body of the essential blood cells that carry oxygen and fight infections.
Cancer metastasis – the spread of disease from the original site to a distant organ – remains a major challenge in treating cancer and a main cause of morbidity and mortality.
In a recent bioRxiv* preprint research paper, a large group of US scientists demonstrate how a booster dose of the mRNA-1273 vaccine can substantially improve both the potency and range of neutralizing antibody responses and mediate protection against upper and lower airway infection by a range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern – even those relatively resistant to in vitro neutralization.
It is well known that type 2 diabetes is largely a preventable chronic disease with proper nutrition, regular physical activity and the maintenance of a healthy body weight. Yet despite growing awareness, the Canadian Diabetes Association (CDA) reports that more than three million Canadians currently have diabetes, with an overwhelming 90% of cases reflecting type 2 diabetes. The CDA also suggests that a child born in the year 2000 has a frightening 1 in 3 chance of developing diabetes.
› Verified 1 days ago
| Entity Name | Aitkin Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942277835 PECOS PAC ID: 4981514692 Enrollment ID: O20031107000093 |
News Archive
New treatment options are badly needed for acute myeloid leukemia, a relatively rare form of cancer. The malignancy begins in the bone marrow, and from there can spread rapidly to the bloodstream, depriving the body of the essential blood cells that carry oxygen and fight infections.
Cancer metastasis – the spread of disease from the original site to a distant organ – remains a major challenge in treating cancer and a main cause of morbidity and mortality.
In a recent bioRxiv* preprint research paper, a large group of US scientists demonstrate how a booster dose of the mRNA-1273 vaccine can substantially improve both the potency and range of neutralizing antibody responses and mediate protection against upper and lower airway infection by a range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern – even those relatively resistant to in vitro neutralization.
It is well known that type 2 diabetes is largely a preventable chronic disease with proper nutrition, regular physical activity and the maintenance of a healthy body weight. Yet despite growing awareness, the Canadian Diabetes Association (CDA) reports that more than three million Canadians currently have diabetes, with an overwhelming 90% of cases reflecting type 2 diabetes. The CDA also suggests that a child born in the year 2000 has a frightening 1 in 3 chance of developing diabetes.
› Verified 1 days ago
| Entity Name | County Of Kanabec |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528031390 PECOS PAC ID: 0648187237 Enrollment ID: O20031125000660 |
News Archive
New treatment options are badly needed for acute myeloid leukemia, a relatively rare form of cancer. The malignancy begins in the bone marrow, and from there can spread rapidly to the bloodstream, depriving the body of the essential blood cells that carry oxygen and fight infections.
Cancer metastasis – the spread of disease from the original site to a distant organ – remains a major challenge in treating cancer and a main cause of morbidity and mortality.
In a recent bioRxiv* preprint research paper, a large group of US scientists demonstrate how a booster dose of the mRNA-1273 vaccine can substantially improve both the potency and range of neutralizing antibody responses and mediate protection against upper and lower airway infection by a range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern – even those relatively resistant to in vitro neutralization.
It is well known that type 2 diabetes is largely a preventable chronic disease with proper nutrition, regular physical activity and the maintenance of a healthy body weight. Yet despite growing awareness, the Canadian Diabetes Association (CDA) reports that more than three million Canadians currently have diabetes, with an overwhelming 90% of cases reflecting type 2 diabetes. The CDA also suggests that a child born in the year 2000 has a frightening 1 in 3 chance of developing diabetes.
› Verified 1 days ago
| Entity Name | Astera Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134305162 PECOS PAC ID: 2961395272 Enrollment ID: O20040202001082 |
News Archive
New treatment options are badly needed for acute myeloid leukemia, a relatively rare form of cancer. The malignancy begins in the bone marrow, and from there can spread rapidly to the bloodstream, depriving the body of the essential blood cells that carry oxygen and fight infections.
Cancer metastasis – the spread of disease from the original site to a distant organ – remains a major challenge in treating cancer and a main cause of morbidity and mortality.
In a recent bioRxiv* preprint research paper, a large group of US scientists demonstrate how a booster dose of the mRNA-1273 vaccine can substantially improve both the potency and range of neutralizing antibody responses and mediate protection against upper and lower airway infection by a range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern – even those relatively resistant to in vitro neutralization.
It is well known that type 2 diabetes is largely a preventable chronic disease with proper nutrition, regular physical activity and the maintenance of a healthy body weight. Yet despite growing awareness, the Canadian Diabetes Association (CDA) reports that more than three million Canadians currently have diabetes, with an overwhelming 90% of cases reflecting type 2 diabetes. The CDA also suggests that a child born in the year 2000 has a frightening 1 in 3 chance of developing diabetes.
› Verified 1 days ago
| Entity Name | Cuyuna Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861414518 PECOS PAC ID: 9537146550 Enrollment ID: O20040707000501 |
News Archive
New treatment options are badly needed for acute myeloid leukemia, a relatively rare form of cancer. The malignancy begins in the bone marrow, and from there can spread rapidly to the bloodstream, depriving the body of the essential blood cells that carry oxygen and fight infections.
Cancer metastasis – the spread of disease from the original site to a distant organ – remains a major challenge in treating cancer and a main cause of morbidity and mortality.
In a recent bioRxiv* preprint research paper, a large group of US scientists demonstrate how a booster dose of the mRNA-1273 vaccine can substantially improve both the potency and range of neutralizing antibody responses and mediate protection against upper and lower airway infection by a range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern – even those relatively resistant to in vitro neutralization.
It is well known that type 2 diabetes is largely a preventable chronic disease with proper nutrition, regular physical activity and the maintenance of a healthy body weight. Yet despite growing awareness, the Canadian Diabetes Association (CDA) reports that more than three million Canadians currently have diabetes, with an overwhelming 90% of cases reflecting type 2 diabetes. The CDA also suggests that a child born in the year 2000 has a frightening 1 in 3 chance of developing diabetes.
› Verified 1 days ago
| Entity Name | Astera Health |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1477545333 PECOS PAC ID: 2961395272 Enrollment ID: O20060504000722 |
News Archive
New treatment options are badly needed for acute myeloid leukemia, a relatively rare form of cancer. The malignancy begins in the bone marrow, and from there can spread rapidly to the bloodstream, depriving the body of the essential blood cells that carry oxygen and fight infections.
Cancer metastasis – the spread of disease from the original site to a distant organ – remains a major challenge in treating cancer and a main cause of morbidity and mortality.
In a recent bioRxiv* preprint research paper, a large group of US scientists demonstrate how a booster dose of the mRNA-1273 vaccine can substantially improve both the potency and range of neutralizing antibody responses and mediate protection against upper and lower airway infection by a range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern – even those relatively resistant to in vitro neutralization.
It is well known that type 2 diabetes is largely a preventable chronic disease with proper nutrition, regular physical activity and the maintenance of a healthy body weight. Yet despite growing awareness, the Canadian Diabetes Association (CDA) reports that more than three million Canadians currently have diabetes, with an overwhelming 90% of cases reflecting type 2 diabetes. The CDA also suggests that a child born in the year 2000 has a frightening 1 in 3 chance of developing diabetes.
› Verified 1 days ago
| Entity Name | Advanced Specialty Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265583652 PECOS PAC ID: 0446353643 Enrollment ID: O20070308000273 |
News Archive
New treatment options are badly needed for acute myeloid leukemia, a relatively rare form of cancer. The malignancy begins in the bone marrow, and from there can spread rapidly to the bloodstream, depriving the body of the essential blood cells that carry oxygen and fight infections.
Cancer metastasis – the spread of disease from the original site to a distant organ – remains a major challenge in treating cancer and a main cause of morbidity and mortality.
In a recent bioRxiv* preprint research paper, a large group of US scientists demonstrate how a booster dose of the mRNA-1273 vaccine can substantially improve both the potency and range of neutralizing antibody responses and mediate protection against upper and lower airway infection by a range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern – even those relatively resistant to in vitro neutralization.
It is well known that type 2 diabetes is largely a preventable chronic disease with proper nutrition, regular physical activity and the maintenance of a healthy body weight. Yet despite growing awareness, the Canadian Diabetes Association (CDA) reports that more than three million Canadians currently have diabetes, with an overwhelming 90% of cases reflecting type 2 diabetes. The CDA also suggests that a child born in the year 2000 has a frightening 1 in 3 chance of developing diabetes.
› Verified 1 days ago
| Entity Name | Welia Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528031390 PECOS PAC ID: 6709295496 Enrollment ID: O20220125001227 |
News Archive
New treatment options are badly needed for acute myeloid leukemia, a relatively rare form of cancer. The malignancy begins in the bone marrow, and from there can spread rapidly to the bloodstream, depriving the body of the essential blood cells that carry oxygen and fight infections.
Cancer metastasis – the spread of disease from the original site to a distant organ – remains a major challenge in treating cancer and a main cause of morbidity and mortality.
In a recent bioRxiv* preprint research paper, a large group of US scientists demonstrate how a booster dose of the mRNA-1273 vaccine can substantially improve both the potency and range of neutralizing antibody responses and mediate protection against upper and lower airway infection by a range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern – even those relatively resistant to in vitro neutralization.
It is well known that type 2 diabetes is largely a preventable chronic disease with proper nutrition, regular physical activity and the maintenance of a healthy body weight. Yet despite growing awareness, the Canadian Diabetes Association (CDA) reports that more than three million Canadians currently have diabetes, with an overwhelming 90% of cases reflecting type 2 diabetes. The CDA also suggests that a child born in the year 2000 has a frightening 1 in 3 chance of developing diabetes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kurtis Allen Waters, MD 13359 Isle Dr, Suite 1, Baxter, MN 56425-2221 Ph: (218) 454-8888 | Dr Kurtis Allen Waters, MD 13359 Isle Dr, Suite 1, Baxter, MN 56425-2221 Ph: (218) 454-8888 |
News Archive
New treatment options are badly needed for acute myeloid leukemia, a relatively rare form of cancer. The malignancy begins in the bone marrow, and from there can spread rapidly to the bloodstream, depriving the body of the essential blood cells that carry oxygen and fight infections.
Cancer metastasis – the spread of disease from the original site to a distant organ – remains a major challenge in treating cancer and a main cause of morbidity and mortality.
In a recent bioRxiv* preprint research paper, a large group of US scientists demonstrate how a booster dose of the mRNA-1273 vaccine can substantially improve both the potency and range of neutralizing antibody responses and mediate protection against upper and lower airway infection by a range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern – even those relatively resistant to in vitro neutralization.
It is well known that type 2 diabetes is largely a preventable chronic disease with proper nutrition, regular physical activity and the maintenance of a healthy body weight. Yet despite growing awareness, the Canadian Diabetes Association (CDA) reports that more than three million Canadians currently have diabetes, with an overwhelming 90% of cases reflecting type 2 diabetes. The CDA also suggests that a child born in the year 2000 has a frightening 1 in 3 chance of developing diabetes.
› Verified 1 days ago
Philip Manger, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 13359 Isle Dr Ste 1, Baxter, MN 56425 Phone: 218-454-8888 Fax: 888-835-7231 |